Cytomegalovirus disease in liver transplant recipients: impact of acyclovir prophylaxis

Transplant Proc. 1993 Jun;25(3):2282-3.

Authors

T A Kizilisik¹, J K Preiksaitis, N M Kneteman

Affiliation

¹ Department of Surgery, University of Alberta Hospitals, Edmonton, Canada.

PMID: 8390739

No abstract available

Publication types

Clinical Trial
Comparative Study

MeSH terms

Acyclovir / therapeutic use*
Cytomegalovirus Infections / physiopathology
Cytomegalovirus Infections / prevention & control*
Drug Administration Schedule
Drug Therapy, Combination
Humans
Immunosuppressive Agents / therapeutic use
Liver Transplantation* / immunology
Postoperative Complications / microbiology
Postoperative Complications / prevention & control*
Time Factors

Substances

Immunosuppressive Agents
Acyclovir